Neuromodulatory co-expression in cardiac vagal motor neurons of the Dorsal Motor Nucleus of the Vagus

Abstract

Dorsal Motor Nucleus of the Vagus (DMV) activity is required for cardioprotection from physiological interventions such as remote ischemic pre-conditioning (RIPC). Herein, we discover the transcriptomic phenotypes of cardioprotective DMV neurons, by combining high throughput transcriptomics, 3D anatomical mapping, and neural tracing in 12 week old male and female Sprague Dawley rats. We find that DMV neurons appear to participate in neuromodulatory co-expression, including those that project to the heart. To distinguish potential mechanisms of cardioprotection, we highlight the functional significance of several transcripts in cardiac-projecting DMV neurons and we begin to validate these findings at the protein level. In our sc-RNAseq data we find that Snca (α-synuclein), the cardioprotective neuromodulator Adcyap1 (PACAP), and the neuropeptide Cartpt (CART) are enriched in cardiac-projecting DMV neurons. To contrast our molecular findings in cardioprotective DMV neurons, we have also collected single neuron HT-RTqPCR data from the other source of cardiac vagal motoneurons, the Nucleus Ambiguus (NA). Catecholaminergic transcripts, including Slc18a2 (VMAT2), Ddc, and Th, are enriched in cardiac-projecting DMV neurons relative to those of the NA. These findings implicate catecholaminergic processes, synuclein, and these secreted neuropeptides in cardioprotection. At the protein level, we found PACAP, CART, SNCA and TH enrichment, as well as co-localization of PACAP, TH, and ChAT, in cardiac-projecting DMV neurons. There is consistency between our findings from three spatial transcriptomics techniques and across sexes. Based on these results, we propose a 3D anatomical and molecular map of cardiac vagal motoneurons. This work fills a major gap in the understanding of the cellular mechanisms by which parasympathetic drive provides cardioprotection and provides a future translational path to emulating the positive vagal neuromodulatory effects on heart health. Funding was provided by the R01 HL161696 grant through National Heart, Lung, and Blood institute and the National Institutes of Health Common Fund SPARC Program Grant OT2OD030534. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.